Abstract:Non-alcoholic fatty liver disease is characterized by liver damage and steatosis, which is often accompanied by inflammation. Tartary buckwheat flavone has been shown to have a range of anti-inflammatory effects, but its mechanism of action on non-alcoholic fatty liver disease remains unclear. In this study, a non-alcoholic fatty liver disease model induced by high-fat diet in vivo and HepG2 cells stimulated by palmitic acid in vitro were constructed, and the effect of tartary buckwheat flavone on high-fat diet-induced non-alcoholic fatty liver disease and its potential mechanism was explored by H&E staining, PCR, Western blot, and 16S rRNA high-throughput sequencing. The results showed that compared with the high-fat diet group, tartary buckwheat flavone significantly reduced liver and body weight and alleviated pathological damage of liver tissue in mice, and the biochemical indexes of total cholesterol, triacylglyceride, alanine aminotransferase, and aspartate aminotransferase were significantly decreased. Further studies showed that tartary buckwheat flavone significantly reduced the protein levels of inflammatory mediators myeloperoxidase, iNOS, COX2, IL-6, IL-1β, and TNF-α. In vitro studies also showed that tartary buckwheat flavone significantly improved palmitic acid–induced HepG2 cell lipid accumulation and increased inflammatory factors. Mechanism studies showed that tartary buckwheat flavone alleviated the disorder of lipid metabolism by activating AMPK, decreasing sterol regulatory element-binding protein-1 (SREBP1) and acetyl-COA carboxylase protein levels. Tartary buckwheat flavone significantly inhibited high-fat diet-induced MAPK and NF-κB signaling pathways to reduce the release of pro-inflammatory mediators, and then alleviate the inflammatory response. In addition, tartary buckwheat flavone significantly alleviated the intestinal flora disorder induced by high-fat diet through increasing the relative abundance of beneficial bacteria Dubosiella and Bacteroidetes. Our study found that tartary buckwheat flavone alleviates non-alcoholic fatty liver disease by mitigating the disorder of lipid metabolism and inflammatory response and regulating the composition of intestinal flora.Graphical Abstract

Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora

The important role of glycerophospholipid metabolism in the protective effects of polyphenol-enriched Tartary buckwheat extract against alcoholic liver disease

Tartary Buckwheat Flavonoids Alleviates High-Fat Diet Induced Kidney Fibrosis in Mice by Inhibiting MAPK and TGF-β1/Smad Signaling Pathway.

Tartary buckwheat root polysaccharides ameliorate non-alcoholic fatty liver disease via the IL6-SOCS3-SREBP1c pathway

Antioxidant and Antidiabetic Properties of Tartary Buckwheat Rice Flavonoids after in Vitro Digestion

The protective mechanism of common buckwheat (Fagopyrum esculentum Moench.) against non-alcoholic fatty liver disease associated with dyslipidemia in mice fed a high-fat and high-cholesterol diet.

Tartary Buckwheat Flavonoids Ameliorate High Fructose-Induced Insulin Resistance and Oxidative Stress Associated with the Insulin Signaling and Nrf2/Ho-1 Pathways in Mice

Tartary Buckwheat Flavonoids Improve Colon Lesions and Modulate Gut Microbiota Composition in Diabetic Mice

Effects of extracted oil of fermented Tartary buckwheat on lipid-lowering, inflammation modulation, and gut microbial regulation in mice

Evaluation of lipid-lowering and immunomodulatory activities of extract oil of Tartary buckwheat fermented by Monascus purpureus in mice

Effects of Total Flavonoids Extracted From Tartary Buckwheat Bran on Blood Fat and Antioxidation in Hyperlipemia Rats

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism

Probiotic-fermented black tartary buckwheat alleviates hyperlipidemia and gut microbiota dysbiosis in rats fed with a high-fat diet

Total Flavonoids of Broussonetia Papyrifera Alleviate Non-Alcohol Fatty Liver Disease Via Regulating Nrf2/AMPK/mTOR Signaling Pathways

Effects of Flaxseed Powder in Improving Non-Alcoholic Fatty Liver by Regulating Gut Microbiota-Bile Acids Metabolic Pathway Through FXR/TGR5 Mediating.

Fuzi-lizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling Pathway

Tartary Buckwheat Flavonoids Protect Hepatic Cells Against High Glucose-Induced Oxidative Stress And Insulin Resistance Via Mapk Signaling Pathways

Transcriptomic and Metabonomic Profiling Reveals the Antihyperlipidemic Effects of Tartary Buckwheat Sprouts in High-Fat-Diet-Fed Mice

Effect of Theaflavin-3,3′-digallate on Leptin-Deficient Induced Nonalcoholic Fatty Liver Disease Might Be Related to Lipid Metabolism Regulated by the Fads1/PPARδ/Fabp4 Axis and Gut Microbiota

Tartary Buckwheat Extracts Regulate Insulin Sensitivity Through IKKβ/IR/IRS-1/Akt Pathway under Inflammation Condition in Mice

Protective effects of tartary buckwheat flavonoids on high TMAO diet-induced vascular dysfunction and liver injury in mice